Pharmacogenomic Polymorphism Analysis of Indigenous Ethnic Minorities of Sino-Tibetan Language Family in Guizhou
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Dataset for the manuscript entitled “Pharmacogenomic Polymorphism Analysis of Indigenous Ethnic Minorities of the Sino-Tibetan Language Family in Guizhou” (submitted to Human Genomics, Submission ID: d7a9d124-77f9-44c3-8dbf-d519619774d1). This dataset contains pharmacogenomic polymorphism data derived from 512 healthy individuals representing 12 indigenous ethnic minorities of the Sino‑Tibetan language family in Guizhou, China. All data were generated using 5.5× low‑coverage whole‑genome sequencing. Detailed supporting information is available in the manuscript’s Supplementary Tables: S1: Frequency of common potentially deleterious variants in the Sino‑Tibetan (ST) population S2: Frequency distribution of potentially deleterious variant sites across global populations S3: Pharmacogenes associated with potentially deleterious variant sites S4: Detailed information on drug metabolic pathways S5: Information on 4,589 clinically annotated SNPs This dataset provides a valuable genetic reference for the implementation of precision medicine among ethnic minority populations in southwest China.
Fields of Study & Subjects
Pharmacogenetics and Drug Metabolism
Genetic Associations and Epidemiology
Race
Genetics
and Society
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 28 March 2026
- Language
- EN
- Document type
- Dataset